These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12193983)

  • 1. [Methods for the determination of factor XIII/XIIIa].
    Wilmer M; Schröder V; Kohler HP
    Hamostaseologie; 2002 Feb; 22(1):32-42. PubMed ID: 12193983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrates of Factor XIII-A: roles in thrombosis and wound healing.
    Richardson VR; Cordell P; Standeven KF; Carter AM
    Clin Sci (Lond); 2013 Feb; 124(3):123-37. PubMed ID: 23075332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
    Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
    J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of factor XIII activity in plasma.
    Katona É; Pénzes K; Molnár É; Muszbek L
    Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis.
    Hethershaw EL; Cilia La Corte AL; Duval C; Ali M; Grant PJ; Ariëns RA; Philippou H
    J Thromb Haemost; 2014 Feb; 12(2):197-205. PubMed ID: 24261582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII and venous thromboembolism.
    Bereczky Z; Muszbek L
    Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.
    Byrnes JR; Duval C; Wang Y; Hansen CE; Ahn B; Mooberry MJ; Clark MA; Johnsen JM; Lord ST; Lam WA; Meijers JC; Ni H; Ariëns RA; Wolberg AS
    Blood; 2015 Oct; 126(16):1940-8. PubMed ID: 26324704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.
    Nikolajsen CL; Dyrlund TF; Poulsen ET; Enghild JJ; Scavenius C
    J Biol Chem; 2014 Mar; 289(10):6526-6534. PubMed ID: 24443567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII.
    Nielsen VG; Kirklin JK
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):793-800. PubMed ID: 19002046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of blood coagulation factor XIII.
    Schmitz T; Bäuml CA; Imhof D
    Anal Biochem; 2020 Sep; 605():113708. PubMed ID: 32335064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
    Nielsen VG; Steenwyk BL; Gurley WQ
    J Heart Lung Transplant; 2006 Oct; 25(10):1247-52. PubMed ID: 17045938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent crosslinking of von Willebrand factor to fibrin.
    Hada M; Kaminski M; Bockenstedt P; McDonagh J
    Blood; 1986 Jul; 68(1):95-101. PubMed ID: 2872929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of factor XIII in ischemic stroke: a key molecule promoting thrombus stabilization and resistance to lysis.
    Marta-Enguita J; Navarro-Oviedo M; Machado FJDM; Bermejo R; Aymerich N; Herrera M; Zandio B; Pagola J; Juega J; Marta-Moreno J; Rodriguez JA; Páramo JA; Roncal C; Muñoz R; Orbe J
    J Thromb Haemost; 2024 Apr; 22(4):1080-1093. PubMed ID: 38160727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factor XIII in man: a review].
    Dufner GS; Marbet GA
    Hamostaseologie; 2002 Feb; 22(1):11-9. PubMed ID: 12193980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions.
    Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M
    Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a).
    Pasternack R; Büchold C; Jähnig R; Pelzer C; Sommer M; Heil A; Florian P; Nowak G; Gerlach U; Hils M
    J Thromb Haemost; 2020 Jan; 18(1):191-200. PubMed ID: 31578814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of factor XIIIa activity on human whole blood clot lysis in vitro.
    Jansen JW; Haverkate F; Koopman J; Nieuwenhuis HK; Kluft C; Boschman TA
    Thromb Haemost; 1987 Apr; 57(2):171-5. PubMed ID: 2440124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.